Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor

被引:55
|
作者
Olieman, AFT
vanGinkel, RJ
Hoekstra, HJ
Mooyaart, EL
Molenaar, WM
Koops, HS
机构
[1] UNIV GRONINGEN HOSP,DEPT SURG ONCOL,NL-9700 RB GRONINGEN,NETHERLANDS
[2] UNIV GRONINGEN HOSP,DEPT RADIOL,NL-9700 RB GRONINGEN,NETHERLANDS
[3] UNIV GRONINGEN HOSP,DEPT PATHOL,NL-9700 RB GRONINGEN,NETHERLANDS
关键词
hyperthermic isolated limb perfusion; angiography; sarcoma; tumor necrosis factor;
D O I
10.1007/BF02316812
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Hyperthermic isolated limb perfusion (HILP) with tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma), and melphalan is associated with a dramatic anti-tumor effect in which the neo-vascularization of the tumor is supposed to be the major target, The aim of the present study was to correlate the angiographic findings with the pathological response in patients undergoing HILP for locally advanced soft-tissue sarcoma, Patients and Methods: Twenty-five patients, 14 male and 11 female, mean age 47 years (range 18-80) were studied. Angiographies were performed before and a median period of 7 weeks (range 4-14 weeks) after HILP. Eight weeks after perfusion, the residual tumor mass was resected and pathologically examined, The changes in tumor vascularization after treatment were scored and compared with the pathological response, Results: All baseline angiograms showed a hypervascular tumor. After HILP, a normal angiography result (NA) was observed in 18 patients (72%) and an abnormal angiography result (AA) was observed in seven patients (28%). All patients with an NA showed a pathologically complete response (pCR) or a pathological partial response with >90% necrosis of the tumor, Of seven patients with an AA, pathological examination showed a PCR in one patient, 10-50% viable tumor volume in four patients, and no pathological response after perfusion in two patients. A good correlation was seen between angiographic and pathological classification (p < 0.001), Conclusion: An angiography performed after hyperthermic isolated limb perfusion with TNF-alpha and melphalan provides a good indication, regardless of whether a good pathological response is expected.
引用
收藏
页码:64 / 69
页数:6
相关论文
共 50 条
  • [21] Hyperthermic isolated limb perfusion with TNF and Melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy
    Thijssens, KM
    Van Ginkel, RJ
    Pras, E
    Suurmeijer, AJ
    Hollander, M
    Hoekstra, HJ
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S35 - S36
  • [22] Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: Three time periods at risk for amputation
    van Ginkel, Robert J.
    Thijssens, Katja M. J.
    Pras, Elisabeth
    Van der Graaf, Winette T. A.
    Suurmeijer, Albert J. H.
    Hoekstra, Harald J.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (04) : 1499 - 1506
  • [23] Isolated Limb Perfusion with Tumor Necrosis Factor Alpha and Melphalan for Locally Advanced Soft Tissue Sarcoma: Three Time Periods at Risk for Amputation
    Robert J. van Ginkel
    Katja M. J. Thijssens
    Elisabeth Pras
    Winette T. A. van der Graaf
    Albert J. H. Suurmeijer
    Harald J. Hoekstra
    Annals of Surgical Oncology, 2007, 14 : 1499 - 1506
  • [24] Isolated limb perfusion for malignant melanoma and locally advanced soft tissue sarcoma
    Kettelhack, C.
    ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE, 2009, 23 (01): : 50 - 54
  • [25] HYPERTHERMIC LIMB PERFUSION FOR MALIGNANT-MELANOMA AND SOFT-TISSUE SARCOMA
    KETTELHACK, C
    KRAUS, T
    HUPP, T
    MANNER, M
    SCHLAG, P
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1990, 16 (04): : 370 - 375
  • [26] L-[1-11C]-tyrosine PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma and skin cancer
    van Ginkel, RJ
    Kole, AC
    Nieweg, OE
    Molenaar, WM
    Pruim, J
    Koops, HS
    Vaalburg, W
    Hoekstra, HJ
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (02) : 262 - 267
  • [27] Hyperthermic isolated limb perfusion in locally advanced limb soft tissue sarcoma: A 24-year single-centre experience
    Rastrelli, Marco
    Campana, Luca Giovanni
    Valpione, Sara
    Tropea, Saveria
    Zanon, Antonio
    Rossi, Carlo Riccardo
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2016, 32 (02) : 165 - 172
  • [28] Hyperthermic isolated limb perfusion with tumor necrosis factor-α and melphalan in patients with locally advanced soft tissue sarcomas:: Treatment response and clinical outcome related to changes in proliferation and apoptosis
    Plaat, BEC
    Molenaar, WM
    Mastik, MF
    Koudstaal, J
    van den Berg, E
    Koops, HS
    Hoekstra, HJ
    CLINICAL CANCER RESEARCH, 1999, 5 (07) : 1650 - 1657
  • [29] ISOLATED HYPERTHERMIC EXTREMITY PERFUSION IN MALIGNANT MELANOMAS AND SOFT-TISSUE SARCOMA
    TONAK, J
    HOHENBERGER, W
    GOHL, J
    CHIRURG, 1984, 55 (08): : 499 - 504
  • [30] Isolated limb perfusion with cisplatin and doxorubicin for locally advanced soft tissue sarcoma of an extremity
    Eroglu, A
    Kocaoglu, H
    Demirci, S
    Akgül, H
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2000, 26 (03): : 213 - 221